What did Teva have to lose by trying? Whatever up-front money Teva paid to ItalFarmaco in 2002 or 2003 was probably de minimis for a company of Teva’s size.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.